Menu
← Oncology Approval Tracker
FDA DECISION ·
Rybrevant
amivantamab-vmjw · Janssen Biotech
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with locally advanced or metastatic non-small cell lung cancer with an FDA test-confirmed EGFR exon 20 insertion and progression on or after platinum chemotherapy.
LAMPGEN ANALYSIS
Why it matters
The FDA converted the post-platinum single-agent indication alongside a separate first-line combination approval.
What research teams should watch
Distinguish single-agent dosing and prior platinum eligibility from the newly approved frontline regimen.
PRIMARY RECORDS